Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Geoffrois

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
AJNR. American Journal of Neuroradiology|June 23, 2009
CT assessment of woodworkers' nasal adenocarcinomas confirms the origin in the olfactory cleftT Georgel, R Jankowski, P Henrot, et al.
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Contribution of an emergency dermatology consultation in a French cancer centre]M Reigneau, F Granel-Brocard, L Geoffrois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersC Theodore, L Geoffrois, J B Vermorken, et al.
The British Journal of Dermatology|May 31, 2020
Assessment of patient knowledge and completion of advance directives in oncodermatologyE Melgar, G F Escobar, F Granel-Brocard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 8, 2018
[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes]I Troussier, G Klausner, E Blais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'ImmunothérapieA Ravaud, B Audhuy, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)S Culine, P Kerbrat, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
AJNR. American Journal of Neuroradiology|June 23, 2009
CT assessment of woodworkers' nasal adenocarcinomas confirms the origin in the olfactory cleftT Georgel, R Jankowski, P Henrot, et al.
Annales De Dermatologie Et De Venereologie|May 20, 2014
[Contribution of an emergency dermatology consultation in a French cancer centre]M Reigneau, F Granel-Brocard, L Geoffrois, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersC Theodore, L Geoffrois, J B Vermorken, et al.
The British Journal of Dermatology|May 31, 2020
Assessment of patient knowledge and completion of advance directives in oncodermatologyE Melgar, G F Escobar, F Granel-Brocard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 8, 2018
[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes]I Troussier, G Klausner, E Blais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'ImmunothérapieA Ravaud, B Audhuy, F Gomez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)S Culine, P Kerbrat, A Kramar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 1998
An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckM Degardin, J Oliveira, L Geoffrois, et al.
Pageof 4